Mailed Fecal Immunochemical Tests—From Efficacy to Implementation - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Mailed Fecal Immunochemical Testing: Moving From Efficacy to Real-World Implementation

  • By

  • Kevin Selby

  • Ekaterina Plys

  • Bianca Albers

  • October 21, 2026

Share

  • 1

    Mailed FIT outreach increases colorectal cancer screening participation, particularly among underserved populations, and can be delivered without an in-person visit.

  • 2

    In a cluster-randomized trial across Southern California FQHCs, mailed FIT outreach sustained screening rates near 40% over 3 years.

  • 3

    Screening coverage in intervention clinics exceeded control coverage by 11 percentage points in years 1 and 2, but by 3 points at year 3, a nonsignificant difference.

  • 4

    Incomplete outreach in the final year and a possible postpandemic screening rebound in control clinics may explain the smaller year 3 difference, but their contributions are unknown.

  • 5

    Effective FIT outreach depends on context, including organized eligibility registers, proactive invitations, health system infrastructure, and sufficient resources.

Original Source(s)

Related Content